This scenario may be of importance in highly estrogen-sensitive tissues, especially in ERα-overexpressing cancers (e.g., breast tumors), wherein a potential protective action against estrogen-dependent cancer remains closely related to the ratio of active ERβ versus ERα [93,94,95]. This evidence concerns the gene ESR1 and breast neoplasm.